BRAF, KRAS and PIK3CA mutation and sensitivity to Trastuzumab in breast cancer cell line model

S. Patra, V. Young, L. Llewellyn, J.N. Senapati, J. Mathew

Research output: Contribution to journalArticle

5 Citations (Scopus)

Cite this